Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 1/20 | 0.91 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.69 |
| ▸ | MAPT | P10636 | 1/20 | 0.69 |
| ▸ | THRB | P10828 | 1/20 | 0.69 |
| ▸ | CNR1 | P21554 | 1/20 | 0.69 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.63 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.61 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.61 |
| ▸ | TSHR | P16473 | 2/20 | 0.61 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.61 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.61 |
| ▸ | FAAH | O00519 | 2/20 | 0.60 |
| ▸ | F7 | P08709 | 3/20 | 0.59 |
| ▸ | F3 | P13726 | 3/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.59 |
| ▸ | PPARG | P37231 | 2/20 | 0.59 |
| ▸ | PPARD | Q03181 | 2/20 | 0.59 |
| ▸ | PPARA | Q07869 | 2/20 | 0.59 |
| ▸ | DGKA | P23743 | 1/20 | 0.59 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17685834 | 1.00 | MGLL (0.91) | MGLLALDH1A1MAPTTHRBCNR1 | |
| SCHEMBL29513053 | 0.98 | MGLL (0.94) | MGLLALDH1A1MAPTTHRBCNR1 | |
| Ethylene SCHEMBL9014239 | 0.97 | MGLL (0.86) | MGLLALDH1A1MAPTTHRBCNR1 | |
| SCHEMBL3663191 | 0.95 | MGLL (1.00) | MGLLALDH1A1MAPTTHRBCNR1 | |
| SCHEMBL3663195 | 0.95 | MGLL (1.00) | MGLLALDH1A1MAPTTHRBCNR1 | |
| SCHEMBL93861 | 0.95 | MGLL (0.82) | MGLLALDH1A1MAPTTHRBCNR1 | |
| SCHEMBL10715660 | 0.95 | MGLL (0.82) | MGLLALDH1A1MAPTTHRBCNR1 | |
| SCHEMBL10529166 | 0.95 | MGLL (0.82) | MGLLALDH1A1MAPTTHRBCNR1 | |
| SCHEMBL3657147 | 0.95 | MGLL (0.82) | MGLLALDH1A1MAPTTHRBCNR1 | |
| SCHEMBL15664438 | 0.95 | MGLL (0.82) | MGLLALDH1A1MAPTTHRBCNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 172 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115844832-A | Self-assembled nanoparticles of two small-molecule prodrugs capable of adjusting proportion and synchronously releasing two proto-drugs, preparation method and application | 盐城工学院 | 2023-03-28 | — | — | CN | claimed |
| CN-114129735-A | Cabazitaxel-fatty acid conjugate and nano preparation thereof | 苏州裕泰医药科技有限公司 | 2022-03-04 | — | — | CN | claimed |
| CN-111001006-A | Curbitacin B and oxidation response antitumor prodrug co-carried bionic nanoparticle | 沈阳药科大学 | 2020-04-14 | — | — | CN | claimed |
| CN-104342090-B | A kind of lubricant for drilling fluids and its application | 中国石油化工股份有限公司 | 2017-12-15 | — | — | CN | claimed |
| CN-104342090-A | Lubricant for drilling fluid, and application thereof | CHINA PETROLEUM & CHEMICAL | 2015-02-11 | — | — | CN | claimed |
| US-8425784-B2 | Ozonolysis reactions in liquid CO2 and CO2-expanded solvents | UNIVERSITY OF KANSAS (US) | 2013-04-23 | — | — | US | claimed |
| EP-3978269-B1 | TIRE | SUMITOMO RUBBER IND (JP) | 2026-03-11 | — | — | EP | disclosed |
| US-20240327709-A1 | NON-LAMELLAR LIQUID CRYSTAL-FORMING COMPOSITION AND USE THEREOF | FARNEX CORPORATION (JP) | 2024-10-03 | — | — | US | disclosed |
| CN-115624631-B | Bufotalin prodrug self-assembled nanoparticle and preparation method and application thereof | 盐城工学院 | 2024-10-01 | — | — | CN | disclosed |
| US-20240207408-A1 | Solid Solution Compositions and Use in Severe Pain | INFIRST HEALTHCARE LIMITED (GB) | 2024-06-27 | — | — | US | disclosed |
| EP-4378452-A1 | NON-LAMELLAR LIQUID CRYSTAL-FORMING COMPOSITION AND USE THEREOF | Farnex Incorporated (JP) | 2024-06-05 | — | — | EP | disclosed |
| US-11992555-B2 | Solid solution compositions and use in chronic inflammation | INFIRST HEALTHCARE LIMITED (GB) | 2024-05-28 | — | — | US | disclosed |
| CN-117794519-A | Non-lamellar liquid crystal forming composition and use thereof | 法纳克斯株式会社 | 2024-03-29 | — | — | CN | disclosed |
| US-7160945-B1 | Water borne film-forming compositions | THE CURATORS OF THE UNIVERSITY OF MISSOURI (US) | 2007-01-09 | — | — | US | disclosed |
| US-20040039095-A1 | Water borne film-forming compositions | THE CURATORS OF THE UNIVERSITY OF MISSOURI | 2004-02-26 | — | — | US | disclosed |
| EP-1169397-B1 | WATER BORNE FILM-FORMING COMPOSITIONS | UNIV MISSOURI (US) | 2003-07-23 | — | — | EP | disclosed |
| EP-0442653-B1 | Incorporation of desired groups into polymers, the polymers so produced, and compositions containing them | ZENECA LTD (GB) | 1997-08-20 | — | — | EP | disclosed |
| US-5364891-A | Incorporation of desired groups into polymers, the polymers so produced, and compositions containing them | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1994-11-15 | — | — | US | disclosed |
| EP-0442653-A2 | Incorporation of desired groups into polymers, the polymers so produced, and compositions containing them | ZENECA LIMITED (GB) | 1991-08-21 | — | — | EP | disclosed |
| US-4364743-A | ESTER AND MIDDLE OIL | ERNER WILLIAM E | 1982-12-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240327709-A1 | NON-LAMELLAR LIQUID CRYSTAL-FORMING COMPOSITION AND USE THEREOF | ELOVL1, ELOVL5, ELOVL3 | MGLL 29/4885ALDH1A1 3656/4885MAPT 4455/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.